Sanofi
French pharmaceutical company known for Dupixent (with Regeneron), diabetes care (Lantus), vaccines, and rare disease treatments.
Services Offered
Our Take
Sanofi is a major player in diabetes (Lantus insulin), vaccines, and rare diseases. Their Dupixent (partnered with Regeneron) has been a game-changer for severe eczema and asthma. Patient assistance is available but can be complex to navigate - they have multiple programs for different drug categories.
Pros
- ✓Diverse portfolio
- ✓Rare disease expertise
- ✓Global vaccine leader
- ✓Dupixent MyWay program
- ✓Patient assistance available
Cons
- ✗Dupixent expensive without coverage
- ✗Multiple programs = navigation complexity
- ✗Some insulin products facing competition
- ✗Application processes vary by drug
Pricing Details
Sanofi Patient Connection provides assistance for qualifying patients. Dupixent MyWay (with Regeneron) for eczema/asthma drugs.
Best For
- • Diabetes management (Lantus)
- • Eczema/allergies (Dupixent)
- • Vaccines
- • Rare diseases
Coverage
- 📍 Global
Accreditations
- ✓FDA approved
- ✓Best-in-class for Dermatology (PURE 2024, with Regeneron)
Trust Indicators
Years in Business
20+
Last verified: December 21, 2024
⚠️ Important
Always verify pricing and details directly with the provider. Prices shown are estimates based on our research as of December 2024 and may have changed.
This information is for educational purposes only and does not constitute medical advice. Consult with qualified healthcare professionals before making medical decisions.
We may earn a commission if you use our links, but this does not affect our editorial opinions or the information presented.
Opens in new window • direct link